nodes	percent_of_prediction	percent_of_DWPC	metapath
Levetiracetam—SV2A—epilepsy syndrome	0.2	0.882	CbGaD
Levetiracetam—CACNA1B—Gabapentin—epilepsy syndrome	0.12	0.703	CbGbCtD
Levetiracetam—Decreased Central Nervous System Disorganized Electrical Activity—Lamotrigine—epilepsy syndrome	0.0471	0.0959	CiPCiCtD
Levetiracetam—Decreased Central Nervous System Disorganized Electrical Activity—Trimethadione—epilepsy syndrome	0.0471	0.0959	CiPCiCtD
Levetiracetam—Decreased Central Nervous System Disorganized Electrical Activity—Felbamate—epilepsy syndrome	0.0471	0.0959	CiPCiCtD
Levetiracetam—Decreased Central Nervous System Disorganized Electrical Activity—Lacosamide—epilepsy syndrome	0.0471	0.0959	CiPCiCtD
Levetiracetam—Decreased Central Nervous System Disorganized Electrical Activity—Fosphenytoin—epilepsy syndrome	0.0471	0.0959	CiPCiCtD
Levetiracetam—Decreased Central Nervous System Disorganized Electrical Activity—Primidone—epilepsy syndrome	0.0471	0.0959	CiPCiCtD
Levetiracetam—Decreased Central Nervous System Disorganized Electrical Activity—Oxcarbazepine—epilepsy syndrome	0.0471	0.0959	CiPCiCtD
Levetiracetam—Decreased Central Nervous System Disorganized Electrical Activity—Valproic Acid—epilepsy syndrome	0.0357	0.0727	CiPCiCtD
Levetiracetam—Decreased Central Nervous System Disorganized Electrical Activity—Gabapentin—epilepsy syndrome	0.0357	0.0727	CiPCiCtD
Levetiracetam—Decreased Central Nervous System Disorganized Electrical Activity—Zonisamide—epilepsy syndrome	0.0271	0.0551	CiPCiCtD
Levetiracetam—Decreased Central Nervous System Disorganized Electrical Activity—Carbamazepine—epilepsy syndrome	0.023	0.0468	CiPCiCtD
Levetiracetam—Decreased Central Nervous System Disorganized Electrical Activity—Phenytoin—epilepsy syndrome	0.0205	0.0417	CiPCiCtD
Levetiracetam—Decreased Central Nervous System Disorganized Electrical Activity—Topiramate—epilepsy syndrome	0.0196	0.0398	CiPCiCtD
Levetiracetam—ABCC2—epilepsy syndrome	0.0195	0.0862	CbGaD
Levetiracetam—ABCC2—Carbamazepine—epilepsy syndrome	0.0104	0.0611	CbGbCtD
Levetiracetam—ABCC2—Phenytoin—epilepsy syndrome	0.00935	0.0548	CbGbCtD
Levetiracetam—ABCC2—Phenobarbital—epilepsy syndrome	0.00834	0.0489	CbGbCtD
Levetiracetam—ABCB1—epilepsy syndrome	0.00718	0.0317	CbGaD
Levetiracetam—ABCB1—Clobazam—epilepsy syndrome	0.0041	0.0241	CbGbCtD
Levetiracetam—ABCB1—Lamotrigine—epilepsy syndrome	0.00395	0.0232	CbGbCtD
Levetiracetam—ABCB1—Carbamazepine—epilepsy syndrome	0.0034	0.0199	CbGbCtD
Levetiracetam—ABCB1—Phenytoin—epilepsy syndrome	0.00305	0.0179	CbGbCtD
Levetiracetam—ABCB1—Phenobarbital—epilepsy syndrome	0.00272	0.0159	CbGbCtD
Levetiracetam—ABCB1—Midazolam—epilepsy syndrome	0.00268	0.0157	CbGbCtD
Levetiracetam—ABCB1—Diazepam—epilepsy syndrome	0.00258	0.0151	CbGbCtD
Levetiracetam—SV2A—telencephalon—epilepsy syndrome	0.00105	0.103	CbGeAlD
Levetiracetam—SV2A—medulla oblongata—epilepsy syndrome	0.000824	0.0812	CbGeAlD
Levetiracetam—CACNA1B—forebrain—epilepsy syndrome	0.000788	0.0777	CbGeAlD
Levetiracetam—SV2A—midbrain—epilepsy syndrome	0.000753	0.0742	CbGeAlD
Levetiracetam—SV2A—spinal cord—epilepsy syndrome	0.000735	0.0724	CbGeAlD
Levetiracetam—CACNA1B—telencephalon—epilepsy syndrome	0.000725	0.0714	CbGeAlD
Levetiracetam—SV2A—cerebellum—epilepsy syndrome	0.000583	0.0574	CbGeAlD
Levetiracetam—CACNA1B—medulla oblongata—epilepsy syndrome	0.000569	0.0561	CbGeAlD
Levetiracetam—CACNA1B—midbrain—epilepsy syndrome	0.00052	0.0513	CbGeAlD
Levetiracetam—CACNA1B—spinal cord—epilepsy syndrome	0.000508	0.0501	CbGeAlD
Levetiracetam—SV2A—brain—epilepsy syndrome	0.000473	0.0466	CbGeAlD
Levetiracetam—CACNA1B—head—epilepsy syndrome	0.000451	0.0445	CbGeAlD
Levetiracetam—CACNA1B—nervous system—epilepsy syndrome	0.000428	0.0422	CbGeAlD
Levetiracetam—CACNA1B—central nervous system—epilepsy syndrome	0.000412	0.0406	CbGeAlD
Levetiracetam—CACNA1B—cerebellum—epilepsy syndrome	0.000403	0.0397	CbGeAlD
Levetiracetam—CACNA1B—brain—epilepsy syndrome	0.000327	0.0322	CbGeAlD
Levetiracetam—ABCB1—forebrain—epilepsy syndrome	9.18e-05	0.00905	CbGeAlD
Levetiracetam—ABCB1—telencephalon—epilepsy syndrome	8.44e-05	0.00832	CbGeAlD
Levetiracetam—CACNA1B—Transmission across Chemical Synapses—SLC6A1—epilepsy syndrome	8.17e-05	0.0026	CbGpPWpGaD
Levetiracetam—CACNA1B—Transmission across Chemical Synapses—GRIN2A—epilepsy syndrome	8.17e-05	0.0026	CbGpPWpGaD
Levetiracetam—CACNA1B—Transmission across Chemical Synapses—GRIA1—epilepsy syndrome	8.17e-05	0.0026	CbGpPWpGaD
Levetiracetam—ABCB1—Drug Induction of Bile Acid Pathway—ABCC2—epilepsy syndrome	7.97e-05	0.00254	CbGpPWpGaD
Levetiracetam—CACNA1B—Neuronal System—GABRB2—epilepsy syndrome	7.88e-05	0.00251	CbGpPWpGaD
Levetiracetam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SLC4A10—epilepsy syndrome	7.85e-05	0.0025	CbGpPWpGaD
Levetiracetam—CACNA1B—Neuronal System—GAD2—epilepsy syndrome	7.76e-05	0.00247	CbGpPWpGaD
Levetiracetam—CACNA1B—Transmission across Chemical Synapses—CHRNB2—epilepsy syndrome	7.73e-05	0.00247	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PNPO—epilepsy syndrome	7.53e-05	0.0024	CbGpPWpGaD
Levetiracetam—SV2A—Disease—EPM2A—epilepsy syndrome	7.53e-05	0.0024	CbGpPWpGaD
Levetiracetam—SV2A—Disease—NHLRC1—epilepsy syndrome	7.53e-05	0.0024	CbGpPWpGaD
Levetiracetam—CACNA1B—Neuronal System—KCNMA1—epilepsy syndrome	7.36e-05	0.00235	CbGpPWpGaD
Levetiracetam—CACNA1B—Transmission across Chemical Synapses—CHRNA4—epilepsy syndrome	7.02e-05	0.00224	CbGpPWpGaD
Levetiracetam—CACNA1B—Neuronal System—SLC1A3—epilepsy syndrome	7.02e-05	0.00224	CbGpPWpGaD
Levetiracetam—CACNA1B—Neuronal System—KCNJ11—epilepsy syndrome	7.02e-05	0.00224	CbGpPWpGaD
Levetiracetam—CACNA1B—Neuronal System—GRIK2—epilepsy syndrome	7.02e-05	0.00224	CbGpPWpGaD
Levetiracetam—CACNA1B—Neuronal System—GAD1—epilepsy syndrome	6.73e-05	0.00215	CbGpPWpGaD
Levetiracetam—ABCB1—medulla oblongata—epilepsy syndrome	6.63e-05	0.00654	CbGeAlD
Levetiracetam—CACNA1B—Neuronal System—GABBR1—epilepsy syndrome	6.42e-05	0.00205	CbGpPWpGaD
Levetiracetam—CACNA1B—Neuronal System—GRIA1—epilepsy syndrome	6.26e-05	0.00199	CbGpPWpGaD
Levetiracetam—CACNA1B—Neuronal System—GRIN2A—epilepsy syndrome	6.26e-05	0.00199	CbGpPWpGaD
Levetiracetam—CACNA1B—Neuronal System—SLC6A1—epilepsy syndrome	6.26e-05	0.00199	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PFKL—epilepsy syndrome	6.24e-05	0.00199	CbGpPWpGaD
Levetiracetam—CACNA1B—Transmission across Chemical Synapses—BCHE—epilepsy syndrome	6.19e-05	0.00197	CbGpPWpGaD
Levetiracetam—ABCB1—midbrain—epilepsy syndrome	6.06e-05	0.00598	CbGeAlD
Levetiracetam—CACNA1B—Transmission across Chemical Synapses—DLG4—epilepsy syndrome	6.04e-05	0.00193	CbGpPWpGaD
Levetiracetam—CACNA1B—Neuronal System—CHRNB2—epilepsy syndrome	5.93e-05	0.00189	CbGpPWpGaD
Levetiracetam—ABCB1—spinal cord—epilepsy syndrome	5.91e-05	0.00583	CbGeAlD
Levetiracetam—CACNA1B—Transmission across Chemical Synapses—GRIN2B—epilepsy syndrome	5.9e-05	0.00188	CbGpPWpGaD
Levetiracetam—CACNA1B—Transmission across Chemical Synapses—PLCB1—epilepsy syndrome	5.84e-05	0.00186	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—SLC6A8—epilepsy syndrome	5.77e-05	0.00184	CbGpPWpGaD
Levetiracetam—SV2A—Disease—STX1B—epilepsy syndrome	5.7e-05	0.00182	CbGpPWpGaD
Levetiracetam—ABCC2—Constitutive Androstane Receptor Pathway—ABCB1—epilepsy syndrome	5.42e-05	0.00173	CbGpPWpGaD
Levetiracetam—CACNA1B—Calcium Regulation in the Cardiac Cell—YWHAZ—epilepsy syndrome	5.38e-05	0.00172	CbGpPWpGaD
Levetiracetam—CACNA1B—Neuronal System—CHRNA4—epilepsy syndrome	5.38e-05	0.00172	CbGpPWpGaD
Levetiracetam—SV2A—Disease—CPSF4—epilepsy syndrome	5.3e-05	0.00169	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PPP1R3C—epilepsy syndrome	5.3e-05	0.00169	CbGpPWpGaD
Levetiracetam—SV2A—Disease—GBE1—epilepsy syndrome	5.3e-05	0.00169	CbGpPWpGaD
Levetiracetam—ABCB1—head—epilepsy syndrome	5.26e-05	0.00518	CbGeAlD
Levetiracetam—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—epilepsy syndrome	5.16e-05	0.00165	CbGpPWpGaD
Levetiracetam—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—epilepsy syndrome	5.15e-05	0.00164	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—PFKL—epilepsy syndrome	5.12e-05	0.00163	CbGpPWpGaD
Levetiracetam—ABCB1—nervous system—epilepsy syndrome	4.98e-05	0.00491	CbGeAlD
Levetiracetam—ABCC2—ABC-family proteins mediated transport—ABCB1—epilepsy syndrome	4.93e-05	0.00157	CbGpPWpGaD
Levetiracetam—ABCB1—Constitutive Androstane Receptor Pathway—ABCC2—epilepsy syndrome	4.8e-05	0.00153	CbGpPWpGaD
Levetiracetam—ABCB1—central nervous system—epilepsy syndrome	4.8e-05	0.00473	CbGeAlD
Levetiracetam—CACNA1B—Neuronal System—BCHE—epilepsy syndrome	4.74e-05	0.00151	CbGpPWpGaD
Levetiracetam—ABCB1—cerebellum—epilepsy syndrome	4.69e-05	0.00462	CbGeAlD
Levetiracetam—CACNA1B—Neuronal System—DLG4—epilepsy syndrome	4.63e-05	0.00148	CbGpPWpGaD
Levetiracetam—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—epilepsy syndrome	4.57e-05	0.00146	CbGpPWpGaD
Levetiracetam—CACNA1B—Neuronal System—GRIN2B—epilepsy syndrome	4.52e-05	0.00144	CbGpPWpGaD
Levetiracetam—CACNA1B—Neuronal System—PLCB1—epilepsy syndrome	4.47e-05	0.00143	CbGpPWpGaD
Levetiracetam—CACNA1B—Calcium Regulation in the Cardiac Cell—PRKCB—epilepsy syndrome	4.44e-05	0.00142	CbGpPWpGaD
Levetiracetam—SV2A—Disease—ST3GAL3—epilepsy syndrome	4.41e-05	0.00141	CbGpPWpGaD
Levetiracetam—ABCB1—ABC-family proteins mediated transport—ABCC2—epilepsy syndrome	4.37e-05	0.00139	CbGpPWpGaD
Levetiracetam—ABCB1—Drug Induction of Bile Acid Pathway—VDR—epilepsy syndrome	4.22e-05	0.00134	CbGpPWpGaD
Levetiracetam—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C19—epilepsy syndrome	3.98e-05	0.00127	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—NT5E—epilepsy syndrome	3.88e-05	0.00124	CbGpPWpGaD
Levetiracetam—ABCB1—brain—epilepsy syndrome	3.81e-05	0.00375	CbGeAlD
Levetiracetam—ABCC2—NRF2 pathway—TXNRD1—epilepsy syndrome	3.6e-05	0.00115	CbGpPWpGaD
Levetiracetam—CACNA1B—Transmission across Chemical Synapses—PRKCB—epilepsy syndrome	3.51e-05	0.00112	CbGpPWpGaD
Levetiracetam—SV2A—Disease—EIF2AK2—epilepsy syndrome	3.21e-05	0.00102	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PPIA—epilepsy syndrome	2.97e-05	0.000948	CbGpPWpGaD
Levetiracetam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—epilepsy syndrome	2.9e-05	0.000926	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—GDNF—epilepsy syndrome	2.86e-05	0.000911	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—SLC6A1—epilepsy syndrome	2.82e-05	0.000899	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—CLCN2—epilepsy syndrome	2.74e-05	0.000873	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—CLCN6—epilepsy syndrome	2.74e-05	0.000873	CbGpPWpGaD
Levetiracetam—CACNA1B—Neuronal System—PRKCB—epilepsy syndrome	2.69e-05	0.000858	CbGpPWpGaD
Levetiracetam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—epilepsy syndrome	2.49e-05	0.000794	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SLC35A3—epilepsy syndrome	2.44e-05	0.000778	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SLC35A2—epilepsy syndrome	2.44e-05	0.000778	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SLC12A5—epilepsy syndrome	2.44e-05	0.000778	CbGpPWpGaD
Levetiracetam—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—epilepsy syndrome	2.42e-05	0.000772	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—ABCG2—epilepsy syndrome	2.29e-05	0.000729	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—SLC6A4—epilepsy syndrome	2.25e-05	0.000718	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SLC4A10—epilepsy syndrome	2.23e-05	0.000711	CbGpPWpGaD
Levetiracetam—SV2A—Disease—SLC2A1—epilepsy syndrome	2.2e-05	0.000702	CbGpPWpGaD
Levetiracetam—SV2A—Disease—JUNB—epilepsy syndrome	2.19e-05	0.000697	CbGpPWpGaD
Levetiracetam—SV2A—Disease—NOS1—epilepsy syndrome	2.17e-05	0.000692	CbGpPWpGaD
Levetiracetam—SV2A—Disease—HBEGF—epilepsy syndrome	2.07e-05	0.00066	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—SLC2A1—epilepsy syndrome	2.04e-05	0.00065	CbGpPWpGaD
Levetiracetam—SV2A—Disease—AKT3—epilepsy syndrome	2.03e-05	0.000648	CbGpPWpGaD
Levetiracetam—SV2A—Disease—ADAM10—epilepsy syndrome	1.98e-05	0.000633	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—EPO—epilepsy syndrome	1.96e-05	0.000626	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—COX3—epilepsy syndrome	1.95e-05	0.000622	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—HBEGF—epilepsy syndrome	1.92e-05	0.000611	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—NTF3—epilepsy syndrome	1.86e-05	0.000593	CbGpPWpGaD
Levetiracetam—SV2A—Disease—CDC42—epilepsy syndrome	1.85e-05	0.000591	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	1.85e-05	0.000589	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	1.85e-05	0.000589	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	1.85e-05	0.000589	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—CXCL12—epilepsy syndrome	1.83e-05	0.000583	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—epilepsy syndrome	1.81e-05	0.000577	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	1.76e-05	0.000562	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	1.76e-05	0.000562	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CAPN1—epilepsy syndrome	1.75e-05	0.000558	CbGpPWpGaD
Levetiracetam—SV2A—Disease—HES1—epilepsy syndrome	1.7e-05	0.000541	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—HMOX1—epilepsy syndrome	1.68e-05	0.000534	CbGpPWpGaD
Levetiracetam—SV2A—Disease—FYN—epilepsy syndrome	1.65e-05	0.000526	CbGpPWpGaD
Levetiracetam—SV2A—Disease—H2AFX—epilepsy syndrome	1.64e-05	0.000524	CbGpPWpGaD
Levetiracetam—SV2A—Disease—YWHAZ—epilepsy syndrome	1.59e-05	0.000506	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—CXCL12—epilepsy syndrome	1.58e-05	0.000505	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—CD40—epilepsy syndrome	1.57e-05	0.000499	CbGpPWpGaD
Levetiracetam—SV2A—Disease—CCR5—epilepsy syndrome	1.53e-05	0.000487	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—HMOX1—epilepsy syndrome	1.49e-05	0.000474	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—APOD—epilepsy syndrome	1.44e-05	0.000458	CbGpPWpGaD
Levetiracetam—SV2A—Disease—TSC2—epilepsy syndrome	1.42e-05	0.000452	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	1.4e-05	0.000447	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	1.4e-05	0.000447	CbGpPWpGaD
Levetiracetam—SV2A—Disease—APOE—epilepsy syndrome	1.39e-05	0.000443	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	1.34e-05	0.000426	CbGpPWpGaD
Levetiracetam—SV2A—Disease—IL6ST—epilepsy syndrome	1.3e-05	0.000416	CbGpPWpGaD
Levetiracetam—SV2A—Disease—NOS2—epilepsy syndrome	1.29e-05	0.000412	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—CLCN2—epilepsy syndrome	1.29e-05	0.00041	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—CLCN6—epilepsy syndrome	1.29e-05	0.00041	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	1.28e-05	0.000409	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	1.28e-05	0.000409	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	1.28e-05	0.000409	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	1.28e-05	0.000409	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	1.19e-05	0.00038	CbGpPWpGaD
Levetiracetam—Nausea—Propofol—epilepsy syndrome	1.17e-05	0.000167	CcSEcCtD
Levetiracetam—Tension—Gabapentin—epilepsy syndrome	1.17e-05	0.000167	CcSEcCtD
Levetiracetam—Vomiting—Fosphenytoin—epilepsy syndrome	1.17e-05	0.000167	CcSEcCtD
Levetiracetam—Diarrhoea—Felbamate—epilepsy syndrome	1.17e-05	0.000167	CcSEcCtD
Levetiracetam—Vertigo—Pregabalin—epilepsy syndrome	1.16e-05	0.000167	CcSEcCtD
Levetiracetam—Abdominal pain—Lamotrigine—epilepsy syndrome	1.16e-05	0.000167	CcSEcCtD
Levetiracetam—Body temperature increased—Lamotrigine—epilepsy syndrome	1.16e-05	0.000167	CcSEcCtD
Levetiracetam—Dizziness—Diazepam—epilepsy syndrome	1.16e-05	0.000166	CcSEcCtD
Levetiracetam—Infection—Valproic Acid—epilepsy syndrome	1.16e-05	0.000166	CcSEcCtD
Levetiracetam—Leukopenia—Pregabalin—epilepsy syndrome	1.16e-05	0.000166	CcSEcCtD
Levetiracetam—Rash—Fosphenytoin—epilepsy syndrome	1.16e-05	0.000165	CcSEcCtD
Levetiracetam—Dermatitis—Fosphenytoin—epilepsy syndrome	1.16e-05	0.000165	CcSEcCtD
Levetiracetam—Nervousness—Gabapentin—epilepsy syndrome	1.15e-05	0.000165	CcSEcCtD
Levetiracetam—Asthenia—Clonazepam—epilepsy syndrome	1.15e-05	0.000165	CcSEcCtD
Levetiracetam—Rhinitis—Topiramate—epilepsy syndrome	1.15e-05	0.000165	CcSEcCtD
Levetiracetam—Back pain—Gabapentin—epilepsy syndrome	1.15e-05	0.000164	CcSEcCtD
Levetiracetam—Headache—Fosphenytoin—epilepsy syndrome	1.15e-05	0.000164	CcSEcCtD
Levetiracetam—Hepatitis—Topiramate—epilepsy syndrome	1.15e-05	0.000164	CcSEcCtD
Levetiracetam—Nervous system disorder—Valproic Acid—epilepsy syndrome	1.15e-05	0.000164	CcSEcCtD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC35A3—epilepsy syndrome	1.15e-05	0.000366	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC35A2—epilepsy syndrome	1.15e-05	0.000366	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC12A5—epilepsy syndrome	1.15e-05	0.000366	CbGpPWpGaD
Levetiracetam—Thrombocytopenia—Valproic Acid—epilepsy syndrome	1.15e-05	0.000164	CcSEcCtD
Levetiracetam—Asthenia—Phenytoin—epilepsy syndrome	1.15e-05	0.000164	CcSEcCtD
Levetiracetam—Nausea—Midazolam—epilepsy syndrome	1.14e-05	0.000164	CcSEcCtD
Levetiracetam—Hallucination—Topiramate—epilepsy syndrome	1.14e-05	0.000164	CcSEcCtD
Levetiracetam—Diarrhoea—Zonisamide—epilepsy syndrome	1.14e-05	0.000163	CcSEcCtD
Levetiracetam—Pharyngitis—Topiramate—epilepsy syndrome	1.14e-05	0.000163	CcSEcCtD
Levetiracetam—Asthenia—Oxcarbazepine—epilepsy syndrome	1.14e-05	0.000163	CcSEcCtD
Levetiracetam—Pruritus—Clonazepam—epilepsy syndrome	1.14e-05	0.000163	CcSEcCtD
Levetiracetam—Vomiting—Vigabatrin—epilepsy syndrome	1.14e-05	0.000163	CcSEcCtD
Levetiracetam—Skin disorder—Valproic Acid—epilepsy syndrome	1.14e-05	0.000163	CcSEcCtD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	1.14e-05	0.000362	CbGpPWpGaD
Levetiracetam—Cough—Pregabalin—epilepsy syndrome	1.13e-05	0.000162	CcSEcCtD
Levetiracetam—Pruritus—Phenytoin—epilepsy syndrome	1.13e-05	0.000162	CcSEcCtD
Levetiracetam—Connective tissue disorder—Topiramate—epilepsy syndrome	1.13e-05	0.000161	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—EIF2AK2—epilepsy syndrome	1.13e-05	0.00036	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—JUND—epilepsy syndrome	1.13e-05	0.00036	CbGpPWpGaD
Levetiracetam—Rash—Vigabatrin—epilepsy syndrome	1.13e-05	0.000161	CcSEcCtD
Levetiracetam—Dizziness—Felbamate—epilepsy syndrome	1.13e-05	0.000161	CcSEcCtD
Levetiracetam—Dermatitis—Vigabatrin—epilepsy syndrome	1.13e-05	0.000161	CcSEcCtD
Levetiracetam—Pruritus—Oxcarbazepine—epilepsy syndrome	1.12e-05	0.000161	CcSEcCtD
Levetiracetam—Convulsion—Pregabalin—epilepsy syndrome	1.12e-05	0.000161	CcSEcCtD
Levetiracetam—Hypersensitivity—Carbamazepine—epilepsy syndrome	1.12e-05	0.000161	CcSEcCtD
Levetiracetam—Vision blurred—Gabapentin—epilepsy syndrome	1.12e-05	0.00016	CcSEcCtD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	1.12e-05	0.000357	CbGpPWpGaD
Levetiracetam—Headache—Vigabatrin—epilepsy syndrome	1.12e-05	0.00016	CcSEcCtD
Levetiracetam—Vomiting—Diazepam—epilepsy syndrome	1.12e-05	0.00016	CcSEcCtD
Levetiracetam—Anorexia—Valproic Acid—epilepsy syndrome	1.12e-05	0.00016	CcSEcCtD
Levetiracetam—Tremor—Gabapentin—epilepsy syndrome	1.11e-05	0.000159	CcSEcCtD
Levetiracetam—Rash—Diazepam—epilepsy syndrome	1.11e-05	0.000159	CcSEcCtD
Levetiracetam—Dermatitis—Diazepam—epilepsy syndrome	1.11e-05	0.000159	CcSEcCtD
Levetiracetam—Arthralgia—Pregabalin—epilepsy syndrome	1.1e-05	0.000158	CcSEcCtD
Levetiracetam—Myalgia—Pregabalin—epilepsy syndrome	1.1e-05	0.000158	CcSEcCtD
Levetiracetam—Chest pain—Pregabalin—epilepsy syndrome	1.1e-05	0.000158	CcSEcCtD
Levetiracetam—Dizziness—Zonisamide—epilepsy syndrome	1.1e-05	0.000158	CcSEcCtD
Levetiracetam—Headache—Diazepam—epilepsy syndrome	1.1e-05	0.000158	CcSEcCtD
Levetiracetam—Anxiety—Pregabalin—epilepsy syndrome	1.1e-05	0.000157	CcSEcCtD
Levetiracetam—Diarrhoea—Clonazepam—epilepsy syndrome	1.1e-05	0.000157	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	1.1e-05	0.000157	CcSEcCtD
Levetiracetam—Asthenia—Carbamazepine—epilepsy syndrome	1.09e-05	0.000156	CcSEcCtD
Levetiracetam—Agitation—Gabapentin—epilepsy syndrome	1.09e-05	0.000156	CcSEcCtD
Levetiracetam—Diarrhoea—Phenytoin—epilepsy syndrome	1.09e-05	0.000156	CcSEcCtD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	1.09e-05	0.000347	CbGpPWpGaD
Levetiracetam—Nausea—Fosphenytoin—epilepsy syndrome	1.09e-05	0.000156	CcSEcCtD
Levetiracetam—Diarrhoea—Oxcarbazepine—epilepsy syndrome	1.09e-05	0.000155	CcSEcCtD
Levetiracetam—Erythema multiforme—Topiramate—epilepsy syndrome	1.09e-05	0.000155	CcSEcCtD
Levetiracetam—Hypersensitivity—Lamotrigine—epilepsy syndrome	1.09e-05	0.000155	CcSEcCtD
Levetiracetam—Vomiting—Felbamate—epilepsy syndrome	1.08e-05	0.000155	CcSEcCtD
Levetiracetam—Pruritus—Carbamazepine—epilepsy syndrome	1.08e-05	0.000154	CcSEcCtD
Levetiracetam—Rash—Felbamate—epilepsy syndrome	1.07e-05	0.000154	CcSEcCtD
Levetiracetam—Eye disorder—Topiramate—epilepsy syndrome	1.07e-05	0.000154	CcSEcCtD
Levetiracetam—Dermatitis—Felbamate—epilepsy syndrome	1.07e-05	0.000154	CcSEcCtD
Levetiracetam—Vertigo—Gabapentin—epilepsy syndrome	1.07e-05	0.000153	CcSEcCtD
Levetiracetam—Headache—Felbamate—epilepsy syndrome	1.07e-05	0.000153	CcSEcCtD
Levetiracetam—Confusional state—Pregabalin—epilepsy syndrome	1.07e-05	0.000153	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	1.07e-05	0.000153	CcSEcCtD
Levetiracetam—Leukopenia—Gabapentin—epilepsy syndrome	1.06e-05	0.000152	CcSEcCtD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—NOS2—epilepsy syndrome	1.06e-05	0.000339	CbGpPWpGaD
Levetiracetam—Dizziness—Clonazepam—epilepsy syndrome	1.06e-05	0.000152	CcSEcCtD
Levetiracetam—Nausea—Vigabatrin—epilepsy syndrome	1.06e-05	0.000152	CcSEcCtD
Levetiracetam—Vomiting—Zonisamide—epilepsy syndrome	1.06e-05	0.000152	CcSEcCtD
Levetiracetam—Insomnia—Valproic Acid—epilepsy syndrome	1.06e-05	0.000151	CcSEcCtD
Levetiracetam—Asthenia—Lamotrigine—epilepsy syndrome	1.06e-05	0.000151	CcSEcCtD
Levetiracetam—Dizziness—Phenytoin—epilepsy syndrome	1.06e-05	0.000151	CcSEcCtD
Levetiracetam—SV2A—Disease—FGF2—epilepsy syndrome	1.05e-05	0.000336	CbGpPWpGaD
Levetiracetam—Rash—Zonisamide—epilepsy syndrome	1.05e-05	0.00015	CcSEcCtD
Levetiracetam—Infection—Pregabalin—epilepsy syndrome	1.05e-05	0.00015	CcSEcCtD
Levetiracetam—Paraesthesia—Valproic Acid—epilepsy syndrome	1.05e-05	0.00015	CcSEcCtD
Levetiracetam—Dermatitis—Zonisamide—epilepsy syndrome	1.05e-05	0.00015	CcSEcCtD
Levetiracetam—Dizziness—Oxcarbazepine—epilepsy syndrome	1.05e-05	0.00015	CcSEcCtD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC4A10—epilepsy syndrome	1.05e-05	0.000334	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	1.05e-05	0.000334	CbGpPWpGaD
Levetiracetam—Nausea—Diazepam—epilepsy syndrome	1.05e-05	0.00015	CcSEcCtD
Levetiracetam—Headache—Zonisamide—epilepsy syndrome	1.04e-05	0.000149	CcSEcCtD
Levetiracetam—Diarrhoea—Carbamazepine—epilepsy syndrome	1.04e-05	0.000149	CcSEcCtD
Levetiracetam—Pruritus—Lamotrigine—epilepsy syndrome	1.04e-05	0.000149	CcSEcCtD
Levetiracetam—Somnolence—Valproic Acid—epilepsy syndrome	1.04e-05	0.000149	CcSEcCtD
Levetiracetam—Immune system disorder—Topiramate—epilepsy syndrome	1.04e-05	0.000148	CcSEcCtD
Levetiracetam—Nervous system disorder—Pregabalin—epilepsy syndrome	1.04e-05	0.000148	CcSEcCtD
Levetiracetam—Cough—Gabapentin—epilepsy syndrome	1.04e-05	0.000148	CcSEcCtD
Levetiracetam—Thrombocytopenia—Pregabalin—epilepsy syndrome	1.04e-05	0.000148	CcSEcCtD
Levetiracetam—Mediastinal disorder—Topiramate—epilepsy syndrome	1.04e-05	0.000148	CcSEcCtD
Levetiracetam—Dyspepsia—Valproic Acid—epilepsy syndrome	1.03e-05	0.000147	CcSEcCtD
Levetiracetam—Convulsion—Gabapentin—epilepsy syndrome	1.03e-05	0.000147	CcSEcCtD
Levetiracetam—Skin disorder—Pregabalin—epilepsy syndrome	1.03e-05	0.000147	CcSEcCtD
Levetiracetam—Vomiting—Clonazepam—epilepsy syndrome	1.02e-05	0.000146	CcSEcCtD
Levetiracetam—Decreased appetite—Valproic Acid—epilepsy syndrome	1.02e-05	0.000146	CcSEcCtD
Levetiracetam—Alopecia—Topiramate—epilepsy syndrome	1.02e-05	0.000145	CcSEcCtD
Levetiracetam—Vomiting—Phenytoin—epilepsy syndrome	1.02e-05	0.000145	CcSEcCtD
Levetiracetam—Rash—Clonazepam—epilepsy syndrome	1.01e-05	0.000145	CcSEcCtD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	1.01e-05	0.000323	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	1.01e-05	0.000323	CbGpPWpGaD
Levetiracetam—Dermatitis—Clonazepam—epilepsy syndrome	1.01e-05	0.000145	CcSEcCtD
Levetiracetam—Myalgia—Gabapentin—epilepsy syndrome	1.01e-05	0.000145	CcSEcCtD
Levetiracetam—Arthralgia—Gabapentin—epilepsy syndrome	1.01e-05	0.000145	CcSEcCtD
Levetiracetam—Chest pain—Gabapentin—epilepsy syndrome	1.01e-05	0.000145	CcSEcCtD
Levetiracetam—Nausea—Felbamate—epilepsy syndrome	1.01e-05	0.000145	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	1.01e-05	0.000145	CcSEcCtD
Levetiracetam—Vomiting—Oxcarbazepine—epilepsy syndrome	1.01e-05	0.000144	CcSEcCtD
Levetiracetam—Fatigue—Valproic Acid—epilepsy syndrome	1.01e-05	0.000144	CcSEcCtD
Levetiracetam—Anxiety—Gabapentin—epilepsy syndrome	1.01e-05	0.000144	CcSEcCtD
Levetiracetam—Anorexia—Pregabalin—epilepsy syndrome	1.01e-05	0.000144	CcSEcCtD
Levetiracetam—Dizziness—Carbamazepine—epilepsy syndrome	1.01e-05	0.000144	CcSEcCtD
Levetiracetam—Diarrhoea—Lamotrigine—epilepsy syndrome	1.01e-05	0.000144	CcSEcCtD
Levetiracetam—Headache—Clonazepam—epilepsy syndrome	1.01e-05	0.000144	CcSEcCtD
Levetiracetam—Rash—Phenytoin—epilepsy syndrome	1.01e-05	0.000144	CcSEcCtD
Levetiracetam—Mental disorder—Topiramate—epilepsy syndrome	1.01e-05	0.000144	CcSEcCtD
Levetiracetam—Dermatitis—Phenytoin—epilepsy syndrome	1.01e-05	0.000144	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	1.01e-05	0.000144	CcSEcCtD
Levetiracetam—Rash—Oxcarbazepine—epilepsy syndrome	1e-05	0.000143	CcSEcCtD
Levetiracetam—Constipation—Valproic Acid—epilepsy syndrome	1e-05	0.000143	CcSEcCtD
Levetiracetam—Pain—Valproic Acid—epilepsy syndrome	1e-05	0.000143	CcSEcCtD
Levetiracetam—Dermatitis—Oxcarbazepine—epilepsy syndrome	1e-05	0.000143	CcSEcCtD
Levetiracetam—Headache—Phenytoin—epilepsy syndrome	1e-05	0.000143	CcSEcCtD
Levetiracetam—Malnutrition—Topiramate—epilepsy syndrome	1e-05	0.000143	CcSEcCtD
Levetiracetam—Headache—Oxcarbazepine—epilepsy syndrome	9.95e-06	0.000142	CcSEcCtD
Levetiracetam—Nausea—Zonisamide—epilepsy syndrome	9.91e-06	0.000142	CcSEcCtD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—FOS—epilepsy syndrome	9.81e-06	0.000313	CbGpPWpGaD
Levetiracetam—Tension—Topiramate—epilepsy syndrome	9.81e-06	0.00014	CcSEcCtD
Levetiracetam—Confusional state—Gabapentin—epilepsy syndrome	9.78e-06	0.00014	CcSEcCtD
Levetiracetam—Dizziness—Lamotrigine—epilepsy syndrome	9.74e-06	0.000139	CcSEcCtD
Levetiracetam—Nervousness—Topiramate—epilepsy syndrome	9.71e-06	0.000139	CcSEcCtD
Levetiracetam—Vomiting—Carbamazepine—epilepsy syndrome	9.69e-06	0.000139	CcSEcCtD
Levetiracetam—Back pain—Topiramate—epilepsy syndrome	9.67e-06	0.000138	CcSEcCtD
Levetiracetam—Feeling abnormal—Valproic Acid—epilepsy syndrome	9.64e-06	0.000138	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	9.64e-06	0.000138	CcSEcCtD
Levetiracetam—Infection—Gabapentin—epilepsy syndrome	9.64e-06	0.000138	CcSEcCtD
Levetiracetam—Rash—Carbamazepine—epilepsy syndrome	9.61e-06	0.000137	CcSEcCtD
Levetiracetam—SV2A—Disease—MTOR—epilepsy syndrome	9.6e-06	0.000306	CbGpPWpGaD
Levetiracetam—Dermatitis—Carbamazepine—epilepsy syndrome	9.6e-06	0.000137	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	9.57e-06	0.000137	CcSEcCtD
Levetiracetam—Insomnia—Pregabalin—epilepsy syndrome	9.57e-06	0.000137	CcSEcCtD
Levetiracetam—Nausea—Clonazepam—epilepsy syndrome	9.55e-06	0.000137	CcSEcCtD
Levetiracetam—Headache—Carbamazepine—epilepsy syndrome	9.55e-06	0.000137	CcSEcCtD
Levetiracetam—SV2A—Disease—PTGS2—epilepsy syndrome	9.51e-06	0.000303	CbGpPWpGaD
Levetiracetam—Nervous system disorder—Gabapentin—epilepsy syndrome	9.51e-06	0.000136	CcSEcCtD
Levetiracetam—Paraesthesia—Pregabalin—epilepsy syndrome	9.5e-06	0.000136	CcSEcCtD
Levetiracetam—Thrombocytopenia—Gabapentin—epilepsy syndrome	9.5e-06	0.000136	CcSEcCtD
Levetiracetam—Nausea—Phenytoin—epilepsy syndrome	9.48e-06	0.000136	CcSEcCtD
Levetiracetam—Nausea—Oxcarbazepine—epilepsy syndrome	9.43e-06	0.000135	CcSEcCtD
Levetiracetam—Vision blurred—Topiramate—epilepsy syndrome	9.43e-06	0.000135	CcSEcCtD
Levetiracetam—Skin disorder—Gabapentin—epilepsy syndrome	9.42e-06	0.000135	CcSEcCtD
Levetiracetam—Somnolence—Pregabalin—epilepsy syndrome	9.41e-06	0.000135	CcSEcCtD
Levetiracetam—Tremor—Topiramate—epilepsy syndrome	9.37e-06	0.000134	CcSEcCtD
Levetiracetam—Vomiting—Lamotrigine—epilepsy syndrome	9.36e-06	0.000134	CcSEcCtD
Levetiracetam—Rash—Lamotrigine—epilepsy syndrome	9.29e-06	0.000133	CcSEcCtD
Levetiracetam—Dermatitis—Lamotrigine—epilepsy syndrome	9.28e-06	0.000133	CcSEcCtD
Levetiracetam—Abdominal pain—Valproic Acid—epilepsy syndrome	9.25e-06	0.000132	CcSEcCtD
Levetiracetam—Body temperature increased—Valproic Acid—epilepsy syndrome	9.25e-06	0.000132	CcSEcCtD
Levetiracetam—Anorexia—Gabapentin—epilepsy syndrome	9.25e-06	0.000132	CcSEcCtD
Levetiracetam—Headache—Lamotrigine—epilepsy syndrome	9.23e-06	0.000132	CcSEcCtD
Levetiracetam—Decreased appetite—Pregabalin—epilepsy syndrome	9.2e-06	0.000132	CcSEcCtD
Levetiracetam—Agitation—Topiramate—epilepsy syndrome	9.19e-06	0.000131	CcSEcCtD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—COX3—epilepsy syndrome	9.17e-06	0.000292	CbGpPWpGaD
Levetiracetam—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	9.13e-06	0.000131	CcSEcCtD
Levetiracetam—Fatigue—Pregabalin—epilepsy syndrome	9.12e-06	0.00013	CcSEcCtD
Levetiracetam—Nausea—Carbamazepine—epilepsy syndrome	9.05e-06	0.000129	CcSEcCtD
Levetiracetam—Pain—Pregabalin—epilepsy syndrome	9.05e-06	0.000129	CcSEcCtD
Levetiracetam—Constipation—Pregabalin—epilepsy syndrome	9.05e-06	0.000129	CcSEcCtD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	9.03e-06	0.000288	CbGpPWpGaD
Levetiracetam—Vertigo—Topiramate—epilepsy syndrome	8.99e-06	0.000129	CcSEcCtD
Levetiracetam—Leukopenia—Topiramate—epilepsy syndrome	8.95e-06	0.000128	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	8.84e-06	0.000126	CcSEcCtD
Levetiracetam—Insomnia—Gabapentin—epilepsy syndrome	8.77e-06	0.000126	CcSEcCtD
Levetiracetam—Nausea—Lamotrigine—epilepsy syndrome	8.75e-06	0.000125	CcSEcCtD
Levetiracetam—Cough—Topiramate—epilepsy syndrome	8.73e-06	0.000125	CcSEcCtD
Levetiracetam—Feeling abnormal—Pregabalin—epilepsy syndrome	8.72e-06	0.000125	CcSEcCtD
Levetiracetam—Paraesthesia—Gabapentin—epilepsy syndrome	8.71e-06	0.000125	CcSEcCtD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	8.69e-06	0.000277	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	8.69e-06	0.000277	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	8.69e-06	0.000277	CbGpPWpGaD
Levetiracetam—Convulsion—Topiramate—epilepsy syndrome	8.66e-06	0.000124	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Pregabalin—epilepsy syndrome	8.65e-06	0.000124	CcSEcCtD
Levetiracetam—Somnolence—Gabapentin—epilepsy syndrome	8.62e-06	0.000123	CcSEcCtD
Levetiracetam—Hypersensitivity—Valproic Acid—epilepsy syndrome	8.62e-06	0.000123	CcSEcCtD
Levetiracetam—Dyspepsia—Gabapentin—epilepsy syndrome	8.54e-06	0.000122	CcSEcCtD
Levetiracetam—Arthralgia—Topiramate—epilepsy syndrome	8.51e-06	0.000122	CcSEcCtD
Levetiracetam—Myalgia—Topiramate—epilepsy syndrome	8.51e-06	0.000122	CcSEcCtD
Levetiracetam—Chest pain—Topiramate—epilepsy syndrome	8.51e-06	0.000122	CcSEcCtD
Levetiracetam—Anxiety—Topiramate—epilepsy syndrome	8.48e-06	0.000121	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	8.46e-06	0.000121	CcSEcCtD
Levetiracetam—Decreased appetite—Gabapentin—epilepsy syndrome	8.43e-06	0.000121	CcSEcCtD
Levetiracetam—Asthenia—Valproic Acid—epilepsy syndrome	8.4e-06	0.00012	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	8.38e-06	0.00012	CcSEcCtD
Levetiracetam—Fatigue—Gabapentin—epilepsy syndrome	8.36e-06	0.00012	CcSEcCtD
Levetiracetam—Body temperature increased—Pregabalin—epilepsy syndrome	8.36e-06	0.00012	CcSEcCtD
Levetiracetam—Abdominal pain—Pregabalin—epilepsy syndrome	8.36e-06	0.00012	CcSEcCtD
Levetiracetam—ABCB1—Allograft Rejection—CASP8—epilepsy syndrome	8.3e-06	0.000265	CbGpPWpGaD
Levetiracetam—Constipation—Gabapentin—epilepsy syndrome	8.3e-06	0.000119	CcSEcCtD
Levetiracetam—Pain—Gabapentin—epilepsy syndrome	8.3e-06	0.000119	CcSEcCtD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	8.29e-06	0.000264	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	8.29e-06	0.000264	CbGpPWpGaD
Levetiracetam—Pruritus—Valproic Acid—epilepsy syndrome	8.28e-06	0.000118	CcSEcCtD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	8.26e-06	0.000263	CbGpPWpGaD
Levetiracetam—Confusional state—Topiramate—epilepsy syndrome	8.23e-06	0.000118	CcSEcCtD
Levetiracetam—Infection—Topiramate—epilepsy syndrome	8.11e-06	0.000116	CcSEcCtD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	8.05e-06	0.000257	CbGpPWpGaD
Levetiracetam—Diarrhoea—Valproic Acid—epilepsy syndrome	8.01e-06	0.000115	CcSEcCtD
Levetiracetam—Nervous system disorder—Topiramate—epilepsy syndrome	8e-06	0.000114	CcSEcCtD
Levetiracetam—Feeling abnormal—Gabapentin—epilepsy syndrome	7.99e-06	0.000114	CcSEcCtD
Levetiracetam—Thrombocytopenia—Topiramate—epilepsy syndrome	7.99e-06	0.000114	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Gabapentin—epilepsy syndrome	7.93e-06	0.000113	CcSEcCtD
Levetiracetam—Skin disorder—Topiramate—epilepsy syndrome	7.93e-06	0.000113	CcSEcCtD
Levetiracetam—Hypersensitivity—Pregabalin—epilepsy syndrome	7.79e-06	0.000111	CcSEcCtD
Levetiracetam—Anorexia—Topiramate—epilepsy syndrome	7.78e-06	0.000111	CcSEcCtD
Levetiracetam—Dizziness—Valproic Acid—epilepsy syndrome	7.74e-06	0.000111	CcSEcCtD
Levetiracetam—SV2A—Disease—SRC—epilepsy syndrome	7.69e-06	0.000245	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—epilepsy syndrome	7.67e-06	0.000245	CbGpPWpGaD
Levetiracetam—Abdominal pain—Gabapentin—epilepsy syndrome	7.67e-06	0.00011	CcSEcCtD
Levetiracetam—Body temperature increased—Gabapentin—epilepsy syndrome	7.67e-06	0.00011	CcSEcCtD
Levetiracetam—Asthenia—Pregabalin—epilepsy syndrome	7.59e-06	0.000109	CcSEcCtD
Levetiracetam—Pruritus—Pregabalin—epilepsy syndrome	7.49e-06	0.000107	CcSEcCtD
Levetiracetam—Vomiting—Valproic Acid—epilepsy syndrome	7.44e-06	0.000106	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	7.44e-06	0.000106	CcSEcCtD
Levetiracetam—Insomnia—Topiramate—epilepsy syndrome	7.38e-06	0.000106	CcSEcCtD
Levetiracetam—Rash—Valproic Acid—epilepsy syndrome	7.38e-06	0.000106	CcSEcCtD
Levetiracetam—Dermatitis—Valproic Acid—epilepsy syndrome	7.37e-06	0.000105	CcSEcCtD
Levetiracetam—Headache—Valproic Acid—epilepsy syndrome	7.33e-06	0.000105	CcSEcCtD
Levetiracetam—Paraesthesia—Topiramate—epilepsy syndrome	7.33e-06	0.000105	CcSEcCtD
Levetiracetam—Somnolence—Topiramate—epilepsy syndrome	7.26e-06	0.000104	CcSEcCtD
Levetiracetam—Diarrhoea—Pregabalin—epilepsy syndrome	7.24e-06	0.000104	CcSEcCtD
Levetiracetam—Dyspepsia—Topiramate—epilepsy syndrome	7.18e-06	0.000103	CcSEcCtD
Levetiracetam—Hypersensitivity—Gabapentin—epilepsy syndrome	7.15e-06	0.000102	CcSEcCtD
Levetiracetam—Decreased appetite—Topiramate—epilepsy syndrome	7.1e-06	0.000101	CcSEcCtD
Levetiracetam—ABCB1—Metabolism—CA13—epilepsy syndrome	7.09e-06	0.000226	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—JUN—epilepsy syndrome	7.05e-06	0.000225	CbGpPWpGaD
Levetiracetam—Gastrointestinal disorder—Topiramate—epilepsy syndrome	7.05e-06	0.000101	CcSEcCtD
Levetiracetam—Fatigue—Topiramate—epilepsy syndrome	7.04e-06	0.000101	CcSEcCtD
Levetiracetam—Dizziness—Pregabalin—epilepsy syndrome	7e-06	0.0001	CcSEcCtD
Levetiracetam—Constipation—Topiramate—epilepsy syndrome	6.98e-06	9.98e-05	CcSEcCtD
Levetiracetam—Pain—Topiramate—epilepsy syndrome	6.98e-06	9.98e-05	CcSEcCtD
Levetiracetam—Asthenia—Gabapentin—epilepsy syndrome	6.96e-06	9.96e-05	CcSEcCtD
Levetiracetam—Nausea—Valproic Acid—epilepsy syndrome	6.95e-06	9.94e-05	CcSEcCtD
Levetiracetam—Pruritus—Gabapentin—epilepsy syndrome	6.86e-06	9.82e-05	CcSEcCtD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	6.84e-06	0.000218	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—APOD—epilepsy syndrome	6.76e-06	0.000216	CbGpPWpGaD
Levetiracetam—Vomiting—Pregabalin—epilepsy syndrome	6.73e-06	9.62e-05	CcSEcCtD
Levetiracetam—Feeling abnormal—Topiramate—epilepsy syndrome	6.73e-06	9.62e-05	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Topiramate—epilepsy syndrome	6.67e-06	9.55e-05	CcSEcCtD
Levetiracetam—Rash—Pregabalin—epilepsy syndrome	6.67e-06	9.54e-05	CcSEcCtD
Levetiracetam—Dermatitis—Pregabalin—epilepsy syndrome	6.66e-06	9.53e-05	CcSEcCtD
Levetiracetam—Diarrhoea—Gabapentin—epilepsy syndrome	6.64e-06	9.49e-05	CcSEcCtD
Levetiracetam—Headache—Pregabalin—epilepsy syndrome	6.63e-06	9.48e-05	CcSEcCtD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	6.59e-06	0.00021	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	6.59e-06	0.00021	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	6.53e-06	0.000208	CbGpPWpGaD
Levetiracetam—Abdominal pain—Topiramate—epilepsy syndrome	6.45e-06	9.23e-05	CcSEcCtD
Levetiracetam—Body temperature increased—Topiramate—epilepsy syndrome	6.45e-06	9.23e-05	CcSEcCtD
Levetiracetam—Dizziness—Gabapentin—epilepsy syndrome	6.42e-06	9.18e-05	CcSEcCtD
Levetiracetam—ABCB1—Allograft Rejection—IL1B—epilepsy syndrome	6.3e-06	0.000201	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	6.28e-06	0.0002	CbGpPWpGaD
Levetiracetam—Nausea—Pregabalin—epilepsy syndrome	6.28e-06	8.99e-05	CcSEcCtD
Levetiracetam—ABCB1—Allograft Rejection—CASP3—epilepsy syndrome	6.28e-06	0.0002	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—epilepsy syndrome	6.21e-06	0.000198	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—epilepsy syndrome	6.18e-06	0.000197	CbGpPWpGaD
Levetiracetam—Vomiting—Gabapentin—epilepsy syndrome	6.17e-06	8.82e-05	CcSEcCtD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—VEGFA—epilepsy syndrome	6.16e-06	0.000196	CbGpPWpGaD
Levetiracetam—Rash—Gabapentin—epilepsy syndrome	6.12e-06	8.75e-05	CcSEcCtD
Levetiracetam—Dermatitis—Gabapentin—epilepsy syndrome	6.11e-06	8.74e-05	CcSEcCtD
Levetiracetam—Headache—Gabapentin—epilepsy syndrome	6.08e-06	8.69e-05	CcSEcCtD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	6.03e-06	0.000192	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	6.03e-06	0.000192	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	6.03e-06	0.000192	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	6.03e-06	0.000192	CbGpPWpGaD
Levetiracetam—Hypersensitivity—Topiramate—epilepsy syndrome	6.01e-06	8.6e-05	CcSEcCtD
Levetiracetam—Asthenia—Topiramate—epilepsy syndrome	5.86e-06	8.38e-05	CcSEcCtD
Levetiracetam—Pruritus—Topiramate—epilepsy syndrome	5.77e-06	8.26e-05	CcSEcCtD
Levetiracetam—Nausea—Gabapentin—epilepsy syndrome	5.76e-06	8.24e-05	CcSEcCtD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	5.6e-06	0.000179	CbGpPWpGaD
Levetiracetam—Diarrhoea—Topiramate—epilepsy syndrome	5.58e-06	7.99e-05	CcSEcCtD
Levetiracetam—Dizziness—Topiramate—epilepsy syndrome	5.4e-06	7.72e-05	CcSEcCtD
Levetiracetam—ABCB1—Metabolism—CERS1—epilepsy syndrome	5.37e-06	0.000171	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PDXK—epilepsy syndrome	5.37e-06	0.000171	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—FAR1—epilepsy syndrome	5.37e-06	0.000171	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—L2HGDH—epilepsy syndrome	5.37e-06	0.000171	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GLUD1—epilepsy syndrome	5.37e-06	0.000171	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ADK—epilepsy syndrome	5.37e-06	0.000171	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	5.37e-06	0.000171	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	5.34e-06	0.00017	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—VEGFA—epilepsy syndrome	5.33e-06	0.00017	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—AVP—epilepsy syndrome	5.32e-06	0.00017	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	5.27e-06	0.000168	CbGpPWpGaD
Levetiracetam—Vomiting—Topiramate—epilepsy syndrome	5.19e-06	7.42e-05	CcSEcCtD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	5.15e-06	0.000164	CbGpPWpGaD
Levetiracetam—Rash—Topiramate—epilepsy syndrome	5.15e-06	7.36e-05	CcSEcCtD
Levetiracetam—Dermatitis—Topiramate—epilepsy syndrome	5.14e-06	7.35e-05	CcSEcCtD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	5.12e-06	0.000163	CbGpPWpGaD
Levetiracetam—Headache—Topiramate—epilepsy syndrome	5.11e-06	7.31e-05	CcSEcCtD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	4.93e-06	0.000157	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—EPM2A—epilepsy syndrome	4.91e-06	0.000157	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PNPO—epilepsy syndrome	4.91e-06	0.000157	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—NHLRC1—epilepsy syndrome	4.91e-06	0.000157	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GAMT—epilepsy syndrome	4.91e-06	0.000157	CbGpPWpGaD
Levetiracetam—Nausea—Topiramate—epilepsy syndrome	4.85e-06	6.93e-05	CcSEcCtD
Levetiracetam—SV2A—Disease—AKT1—epilepsy syndrome	4.78e-06	0.000152	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	4.76e-06	0.000152	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	4.76e-06	0.000152	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—epilepsy syndrome	4.69e-06	0.00015	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—TNF—epilepsy syndrome	4.57e-06	0.000146	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—QDPR—epilepsy syndrome	4.57e-06	0.000146	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CA4—epilepsy syndrome	4.57e-06	0.000146	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	4.57e-06	0.000146	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—COX3—epilepsy syndrome	4.29e-06	0.000137	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	4.25e-06	0.000135	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	4.1e-06	0.000131	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CACNA2D2—epilepsy syndrome	4.07e-06	0.00013	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—KCNB1—epilepsy syndrome	4.07e-06	0.00013	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PFKL—epilepsy syndrome	4.07e-06	0.00013	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—SLCO1A2—epilepsy syndrome	4.07e-06	0.00013	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—SLC6A8—epilepsy syndrome	4.07e-06	0.00013	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—AKT1—epilepsy syndrome	3.93e-06	0.000125	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	3.88e-06	0.000124	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	3.78e-06	0.000121	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ATIC—epilepsy syndrome	3.72e-06	0.000119	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—UPB1—epilepsy syndrome	3.72e-06	0.000119	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—NEU1—epilepsy syndrome	3.72e-06	0.000119	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	3.7e-06	0.000118	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—HSD17B4—epilepsy syndrome	3.58e-06	0.000114	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	3.52e-06	0.000112	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PPP1R3C—epilepsy syndrome	3.46e-06	0.00011	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GBE1—epilepsy syndrome	3.46e-06	0.00011	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	3.34e-06	0.000106	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ASAH1—epilepsy syndrome	3.25e-06	0.000104	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	3.22e-06	0.000103	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	3.22e-06	0.000103	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—STXBP1—epilepsy syndrome	3.17e-06	0.000101	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	3.1e-06	9.88e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—NT5E—epilepsy syndrome	3.09e-06	9.84e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ALAD—epilepsy syndrome	3.09e-06	9.84e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	3.07e-06	9.78e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	3.01e-06	9.6e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ALDH7A1—epilepsy syndrome	2.94e-06	9.38e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CACNA1A—epilepsy syndrome	2.94e-06	9.38e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ST3GAL3—epilepsy syndrome	2.88e-06	9.18e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ADSL—epilepsy syndrome	2.82e-06	9e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GLUL—epilepsy syndrome	2.77e-06	8.82e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	2.72e-06	8.66e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	2.7e-06	8.61e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	2.63e-06	8.39e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	2.54e-06	8.1e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	2.52e-06	8.05e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	2.5e-06	7.98e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—AQP1—epilepsy syndrome	2.47e-06	7.86e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	2.25e-06	7.19e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CHRM3—epilepsy syndrome	2.23e-06	7.11e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	2.23e-06	7.11e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ABCG2—epilepsy syndrome	1.82e-06	5.8e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	1.77e-06	5.65e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	1.76e-06	5.61e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	1.68e-06	5.35e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	1.59e-06	5.07e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.52e-06	4.83e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	1.51e-06	4.82e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—BCHE—epilepsy syndrome	1.51e-06	4.8e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	1.44e-06	4.58e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PLCB1—epilepsy syndrome	1.42e-06	4.53e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—TH—epilepsy syndrome	1.42e-06	4.52e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—HMOX1—epilepsy syndrome	1.18e-06	3.77e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CAT—epilepsy syndrome	1.17e-06	3.72e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GPX1—epilepsy syndrome	1.06e-06	3.36e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—AGT—epilepsy syndrome	9.25e-07	2.95e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—APOE—epilepsy syndrome	9.07e-07	2.89e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—POMC—epilepsy syndrome	7.79e-07	2.48e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ALB—epilepsy syndrome	7.1e-07	2.26e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PTGS2—epilepsy syndrome	6.21e-07	1.98e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—AKT1—epilepsy syndrome	3.12e-07	9.95e-06	CbGpPWpGaD
